Preparation method of rapamycin
By controlling the phosphate ion concentration and fermentation temperature of the culture medium in rapamycin production, it is divided into four fermentation stages to solve the problem of low rapamycin yield and purity, and the reduction of production costs and efficiency are achieved. promote.
Patent Information
- Application Number
- CN202411563270.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-05
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing rapamycin production technology has problems with low yield and purity, especially for enterprises that do not have biotechnology conditions, and the stability of plasmid transfection is poor.
By controlling the concentration of phosphate ion, fermentation temperature and pH in the culture medium, it is divided into four fermentation stages for fermentation processing, including the first fermentation stage, the second fermentation stage, the third fermentation stage and the fourth fermentation stage, and the fermentation temperature is controlled. and pH changes to enhance fermentation yield and purity of rapamycin.
The fermentation yield and purity of rapamycin is significantly improved, and the production cost is reduced, providing a simple and effective method to improve the production efficiency of rapamycin.
Smart Images

Figure CN119082226A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of bioengineering, and in particular to a method for preparing rapamycin. Background Art
[0002] Rapamycin is currently the most promising new potent immunosuppressant in the world. Its molecular structure is similar to FK506. It is another immunophilic protein binder that can be used for organ transplantation anti-rejection. Its immunosuppressive effect is dozens of times stronger than cyclosporine. It is the immunosuppressant with the lowest nephrotoxicity. It can also be used to treat autoimmune diseases such as rheumatoid arthritis and lupus erythematosus. In September 1999, the US FDA officially approved rapamycin as an anti-rejection drug for kidney transplantation and put it on the market. At the same time, the vascular stent Cypher developed by Cordis with rapamycin as a coating drug was launched in Europe, the United States and Japan in 2002. In terms of anti-tumor, the FDA approved its use in the treatment of renal cell carcinoma, mantle cell lymphoma, tuberous sclerosis and pancreatic cancer in 2007, 2008, 2010 and 2011 respectively, which has broad application prospects.
[0003] Hangzhou Sino-US Huadong Medicine Co., Ltd. has already put into industrial production (Chinese patent CN200810019207.8), and the fermentation capacity of Streptomyces hygroscopicus in 10-ton and 50-ton fermentation tanks is about 600 mg / L. Zhang Wei et al. disclosed the strain selection and cultivation conditions optimization in the article "Reasoning Breeding of Rapamectin High-yielding Strains and Research on New Fermentation Processes" (Master's thesis of Zhejiang University in 2009), and the fermentation capacity in a 20-ton fermentation tank is 700 mg / L.
[0004] In the patent "A method for increasing the production of rapamycin in Streptomyces" (Chinese patent CNCN202010084526), Jiang Weihong found that some target genes involved in the tricarboxylic acid cycle, fatty acid synthesis or aromatic amino acid synthesis pathway in rapamycin production bacteria are closely related to the rapamycin production of the production bacteria. By constructing a plasmid, the constructed plasmid is transformed into Streptomyces rapa to downregulate the expression of the target gene in the rapamycin production bacteria, optimize the recombinant expression system and expression strain, and design an effective recombinant expression construct to achieve rapamycin expression levels of 550mg / L, 800mg / L, and 750mg / L. Using biotechnology to achieve production increase is indeed a good method that requires specialized equipment and specialized technicians, but it is not feasible for enterprises that do not have biotechnology conditions. At the same time, it is well known that the stability of plasmid transfection is not very good.
[0005] Zhao Zhiquan's "Method for Cultivating Streptomyces Hygroscopicus to Produce Rapamycin Fermentation Broth" (Chinese Patent CN201010540111) obtains a fermentation broth with a higher concentration of rapamycin by selecting a culture medium and controlling culture conditions, especially the rotation speed. The rapamycin titer in a 100L fermenter reaches about 900mg / L. Compared with genetic engineering technology and strain mutagenesis technology, increasing the yield of rapamycin by controlling the fermentation process is more practical. Summary of the invention
[0006] In order to solve the above problems, the embodiments of the present application provide a method for preparing rapamycin, which significantly improves the fermentation yield and purity of rapamycin and greatly reduces the production cost by controlling the phosphate ion concentration in the culture medium, the initial pH of the culture medium, and the fermentation parameters at a specific time period during the fermentation process.
[0007] In order to achieve the above purpose, the technical solution adopted in the embodiment of the present application is as follows: In a first aspect, an embodiment of the present application provides a method for preparing rapamycin, wherein the rapamycin strain is processed through four fermentation stages based on fermentation temperature control to obtain a rapamycin fermentation broth, and the rapamycin fermentation broth is separated and extracted to obtain rapamycin; the fermentation stages include a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage; the fermentation temperature of the first fermentation stage is 26 to 30°C, at which time the pH value of the fermentation broth is the initial pH, the fermentation temperature of the second fermentation stage is 20 to 24°C, at which time the pH value of the fermentation broth decreases by 0.5 to 1 pH unit, the fermentation temperature of the third fermentation stage is 25 to 27°C, at which time the pH value of the fermentation broth remains unchanged, the fermentation temperature of the fourth fermentation stage is 27 to 29°C, and the pH value of the fermentation broth gradually increases to 7.2-7.5.
[0008] Furthermore, the fermentation environment of the four fermentation stages is a phosphate-containing fermentation medium.
[0009] Furthermore, the phosphate ion concentration of the fermentation medium is between 0.005% and 0.05%.
[0010] Furthermore, the initial pH of the fermentation medium is 6.2-8.0.
[0011] Furthermore, the dissolved oxygen content in the four fermentation stages is greater than or equal to 60%.
[0012] Furthermore, the end mark of the first fermentation stage is: the concentration of rapamycin bacteria in the fermentation liquid is 10%, and bacterial particles with a size less than 0.1 mm appear.
[0013] Furthermore, the end mark of the second fermentation stage is: the concentration of rapamycin in the fermentation liquid is 20%-25%, and the bacterial particle size develops to 0.5 mm or above.
[0014] Furthermore, the end mark of the third fermentation stage is: the rapamycin concentration in the fermentation broth is 30%-35%, and the rapamycin concentration in the fermentation broth is increased by 10% based on the second fermentation stage.
[0015] Furthermore, the end mark of the fourth fermentation stage is: the bacterial concentration is maintained at the second fermentation stage.
[0016] In the technical solution provided in the embodiment of the present application, the rapamycin fermentation broth is separated and extracted to obtain rapamycin by controlling the four stages of the rapamycin fermentation process, which significantly improves the rapamycin fermentation yield and purity and greatly reduces the production cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] In order to more clearly illustrate the technical solutions in the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0018] Figure 1 It is a flow chart of the method for preparing rapamycin provided in the examples of the present application. DETAILED DESCRIPTION
[0019] To make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be clearly and completely described below. If the specific conditions are not specified in the embodiments, they are carried out according to the normal conditions or the conditions recommended by the manufacturer. If the reagents or instruments used do not specify the manufacturer, they are all conventional products that can be purchased commercially. The embodiments described below are some embodiments of the present invention, rather than all embodiments. In conjunction with the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the art without making creative work are within the scope of protection of the present invention.
[0020] In a specific embodiment of the present invention, the present invention provides a method for preparing rapamycin, by dividing the rapamycin fermentation process into four stages and controlling the four stages. The fermentation environment for rapamycin is a phosphate fermentation medium, wherein the phosphate ion concentration in the fermentation medium is 0.005% to 0.05%, the initial pH value of the fermentation medium is 6.2-8.0, and the dissolved oxygen content of the fermentation medium is greater than or equal to 60%.
[0021] Among them, the four stages in the embodiment of the present application are divided by the change of fermentation temperature, wherein the fermentation temperature of the first fermentation stage is 26-30°C, the fermentation temperature of the second fermentation stage is 20-24°C, the fermentation temperature of the third fermentation stage is 25-27°C, and the fermentation temperature of the fourth fermentation stage is 27-29°C.
[0022] The above four fermentation stages correspond to the four stages of bacterial generation. Specifically, the first fermentation stage is the lag period of the bacteria, during which the bacteria recover and grow slowly; the second fermentation stage is the rapid growth stage of the bacteria, during which the bacteria enter the exponential growth stage; the third fermentation stage, during which the bacteria still grow rapidly, the bacteria begin to adhere to each other, the fermentation liquid gradually becomes viscous, and the target begins to appear; the fourth fermentation stage, during which the bacteria enters the stable period, turns to secondary metabolism, and the target continues to increase. After the fermentation of the above four stages, it enters the final decay period, during which the bacteria enters the decay period and the target stops increasing. In the fourth fermentation stage, due to the loss of the base material of the culture medium, it is necessary to add basal culture medium in the fourth fermentation stage.
[0023] The above four fermentation stages are represented by the following characteristic nodes through data: The end mark of the first fermentation stage is that the concentration of rapamycin in the fermentation broth reaches 10%, and at this time, the pH value of the fermentation broth does not change and maintains the initial pH value.
[0024] The end mark of the second fermentation stage is that the rapamycin concentration in the fermentation broth is 20%-25%, and the pH value of the fermentation broth is reduced to 5.2-7.0.
[0025] The end mark of the third fermentation stage is that the rapamycin concentration in the fermentation liquid is 30%-35%. At this time, the pH value of the fermentation liquid is maintained unchanged at the pH value of the second fermentation stage, that is, 5.2-7.0.
[0026] The end mark for the fourth fermentation stage is that the rapamycin concentration in the fermentation liquid is the same as that in the third fermentation stage, and the pH value of the fermentation liquid is greater than 7.5 and remains unchanged within the unit time, where the unit time can be set specifically and the unit time is the minimum value, that is, the fermentation is completed as long as the pH value remains unchanged within this time.
[0027] The state of the fermentation liquid also changes with the changes in the above fermentation stages. In the first fermentation stage, a large number of extremely large bacterial particles visible to the naked eye appear in the fermentation liquid, and the size of the bacterial particles is less than 0.1mm. In the second fermentation stage, the fermentation liquid becomes thicker, and the bacterial particles in the fermentation liquid can reach 0.5mm and above. In the third fermentation stage, the fermentation liquid becomes obviously viscous and forms a film on the wall. In the fourth fermentation stage, the consistency of the fermentation liquid is reduced compared with the third fermentation stage.
[0028] Specifically, the specific fermentation steps in the embodiments of the present application are: flat plate seed culture-shake flask seed culture-seed tank seed culture-fermentation tank culture, wherein the flat plate seed culture, shake flask seed culture, and seed tank seed culture are all cultured using conventional technical means in the art, and will not be repeated in the embodiments of the present application.
[0029] Among them, the culture environment in the embodiment of the present application is a basic culture medium containing phosphate. For the basic fermentation medium, it is a conventional culture medium for microorganisms, especially actinomycetes, including a quick-acting carbon source such as glucose, a long-acting carbon source such as corn starch, one or more nitrogen sources such as cottonseed protein powder, yeast extract, corn steep powder, etc., and also includes phosphates, calcium salts and defoamers. Among them, phosphate has a significant effect on bacterial growth, and potassium dihydrogen phosphate and dipotassium hydrogen phosphate are usually mixed, and the conventional dosage is 0.2% to 1% or even higher. Among them, the root ions that have an important influence on the production of rapamycin strains are phosphate ions rather than potassium ions. Within a certain range, as the phosphate ion concentration increases, the rapamycin weighing linearly decreases. The phosphate ion concentration suitable for the bacteria in the embodiment of the present application is selected to be lower than the conventional phosphate dosage, and the specific phosphate ion concentration is 0.005 to 0.05%.
[0030] In the process of microbial growth and metabolism, it is divided into primary metabolism and secondary metabolism, among which primary metabolism mainly meets the needs of microbial reproduction, and secondary metabolism is often not necessary for microbial growth and reproduction, and often changes from primary metabolism to secondary metabolism under unfavorable growth environment. Fermentation utilizes these two metabolic characteristics of microorganisms to obtain fermentation products needed by humans. In order to obtain a higher yield, it is necessary to first cultivate a suitable number of microorganisms, and secondly, it is necessary to artificially control external conditions when obtaining a suitable number of microorganisms, break the metabolic control system of microorganisms, and make microorganisms transfer to secondary metabolism in time. Among them, the key to the level of rapamycin production and the amount of impurities lies in controlling the growth rate of the second stage and the conversion from the third stage to the fourth stage. Among them, the yield can be further increased by adjusting the pH and temperature during the conversion process. In addition, in order to further ensure the stability of the fermentation, the basal culture medium can be selectively added to the system in the fourth fermentation stage.
[0031] See also Figure 1 With respect to the above fermentation process, the preparation method provided in the embodiment of the present application comprises the following steps: Step S1. Inoculate rapamycin-producing bacteria into a basic fermentation medium.
[0032] In the examples of the present application, the phosphate ion concentration in the basic fermentation medium is 0.005%, and the initial pH is 6.2.
[0033] Step S2: fermenting the rapamycin-producing bacteria in the first fermentation stage, the second fermentation stage, the third fermentation stage and the fourth fermentation stage in sequence to obtain a fermentation liquid.
[0034] In the embodiment of the present application, the culture temperature for the first fermentation stage is 26-30°C, the culture temperature for the second fermentation stage is 20-24°C, the culture temperature for the third fermentation stage is 25-27°C, and the culture temperature for the fourth fermentation stage is 27-29°C.
[0035] Step S3: separating and extracting the fermentation broth to obtain rapamycin.
[0036] The method for preparing rapamycin of the present invention is further illustrated by specific examples below.
[0037] Example 1 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.005% and the initial pH is 6.2.
[0038] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0039] Among them, the culture temperature in the first fermentation stage is 26°C, the culture temperature in the second fermentation stage is 20°C, the culture temperature in the third fermentation stage is 25°C, and the culture temperature in the fourth fermentation stage is 27°C.
[0040] The total fermentation time is 240h.
[0041] S3. After the fermentation is completed, the fermentation liquid is obtained and separated and extracted to obtain rapamycin.
[0042] In the examples of the present application, the separation and extraction method is carried out using the rapamycin separation and extraction process in the prior art.
[0043] Example 2 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.05% and the initial pH is 8.0.
[0044] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0045] The culture temperature in the first fermentation stage was 30°C, the culture temperature in the second fermentation stage was 22°C, the culture temperature in the third fermentation stage was 27°C, and the culture temperature in the fourth fermentation stage was 29°C.
[0046] The total fermentation time is 240h.
[0047] S3. After the fermentation is completed, the fermentation liquid is obtained and separated and extracted to obtain rapamycin.
[0048] In the examples of the present application, the separation and extraction method is carried out using the rapamycin separation and extraction process in the prior art.
[0049] Example 3 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.01% and the initial pH is 7.0.
[0050] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0051] The culture temperature in the first fermentation stage was 28°C, the culture temperature in the second fermentation stage was 24°C, the culture temperature in the third fermentation stage was 26°C, and the culture temperature in the fourth fermentation stage was 28°C.
[0052] The total fermentation time is 240h.
[0053] S3. After the fermentation is completed, the fermentation liquid is obtained and separated and extracted to obtain rapamycin.
[0054] In the examples of the present application, the separation and extraction method is carried out using the rapamycin separation and extraction process in the prior art.
[0055] Comparative Example 1 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.005% and the initial pH is 6.2.
[0056] S2. The temperature was controlled at 26°C throughout the process and the total fermentation time was 240h.
[0057] S3. After the fermentation is completed, the obtained fermentation liquid is separated and extracted to obtain rapamycin.
[0058] In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0059] Comparative Example 2 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.005% and the initial pH is 6.2.
[0060] S2. The fermentation temperature was controlled at 20°C throughout the whole process, and the total fermentation time was 240 h.
[0061] S3. After the fermentation is completed, the obtained fermentation liquid is separated and extracted to obtain rapamycin.
[0062] In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0063] Comparative Example 3 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.3% and the initial pH is 6.2; S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0064] Specifically, the culture temperature in the first fermentation stage is 26°C, the culture temperature in the second fermentation stage is 20°C, the culture temperature in the third fermentation stage is 25°C, and the culture temperature in the fourth fermentation stage is 27°C.
[0065] The total fermentation time is 240h.
[0066] S3. After the fermentation is completed, the obtained fermentation liquid is separated and extracted to obtain rapamycin.
[0067] In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0068] Comparative Example 4 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.005% and the initial pH is 4.5; S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0069] Specifically, the culture temperature in the first fermentation stage is 26°C, the culture temperature in the second fermentation stage is 20°C, the culture temperature in the third fermentation stage is 25°C, and the culture temperature in the fourth fermentation stage is 27°C.
[0070] The total fermentation time is 240h.
[0071] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0072] Comparative Example 5 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.05% and the initial pH is 8.0; S2. The culture temperature was controlled at 30°C throughout the whole process.
[0073] The total fermentation time is 240h.
[0074] S3. After the fermentation is completed, the obtained fermentation liquid is separated and extracted to obtain rapamycin.
[0075] In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0076] Comparative Example 6 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.05% and the initial pH is 8.0; S2. The culture temperature was controlled at 24°C throughout the whole process.
[0077] The total fermentation time is 240h.
[0078] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0079] Comparative Example 7 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.3% and the initial pH is 8.0; S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0080] Specifically, the culture temperature in the first fermentation stage is 30°C, the culture temperature in the second fermentation stage is 22°C, the culture temperature in the third fermentation stage is 27°C, and the culture temperature in the fourth fermentation stage is 29°C.
[0081] The total fermentation time is 240h.
[0082] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0083] Comparative Example 8 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.05% and the initial pH is 4.5.
[0084] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0085] Specifically, the culture temperature in the first stage is 30°C; the culture temperature in the second stage is 22°C; the culture temperature in the third stage is 27°C; and the culture temperature in the fourth stage is 29°C.
[0086] The total fermentation time is 240h.
[0087] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0088] Comparative Example 9 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.01% and the initial pH is 7.0.
[0089] S2. The culture temperature was controlled at 30°C throughout the whole process.
[0090] The total fermentation time is 240h.
[0091] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0092] Comparative Example 10 S1. inoculating the rapamycin-producing bacteria into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.01% and the initial pH is 7.0; S2. The culture temperature was controlled at 22°C throughout the whole process.
[0093] The total fermentation time is 240h.
[0094] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0095] Comparative Example 11 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.3% and the initial pH is 7.0.
[0096] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0097] The culture temperature in the first stage is 28°C; the culture temperature in the second stage is 24°C; the culture temperature in the third stage is 26°C; and the culture temperature in the fourth stage is 28°C.
[0098] The total fermentation time is 240h.
[0099] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0100] Comparative Example 12 S1. The rapamycin-producing bacteria are inoculated into a basic fermentation medium, wherein the phosphate ion concentration of the fermentation medium is 0.01% and the initial pH is 4.5.
[0101] S2. The rapamycin-producing bacteria are fermented in a first fermentation stage, a second fermentation stage, a third fermentation stage and a fourth fermentation stage to obtain a fermentation liquid.
[0102] Specifically, the culture temperature in the first fermentation stage is 28°C, the culture temperature in the second fermentation stage is 24°C, the culture temperature in the third fermentation stage is 26°C, and the culture temperature in the fourth fermentation stage is 28°C.
[0103] The total fermentation time is 240h.
[0104] S3. After the fermentation is completed, the obtained fermentation broth is separated and extracted to obtain rapamycin; In this comparative example, the same prior art solution as that of Example 1 to Example 3 is adopted for separation and purification, which will not be described in detail in the examples of the present application.
[0105] The above examples 1 to 3 and comparative examples 1 to 12 are explained as follows: The difference between Comparative Examples 1 and 2 and Example 1 is that the temperature is not controlled in stages during the entire fermentation process, but a fixed value is used.
[0106] The difference between Comparative Example 3 and Example 1 is that the phosphate ion concentration of the culture medium is inconsistent.
[0107] The difference between Comparative Example 4 and Example 1 is that the initial pH of the culture medium is inconsistent.
[0108] The difference between Comparative Examples 5 and 6 and Example 2 is that the temperature is not controlled in stages during the entire fermentation process, but a fixed value is used.
[0109] The difference between Comparative Example 7 and Example 2 is that the phosphate ion concentration of the culture medium is inconsistent.
[0110] The difference between Comparative Example 8 and Example 2 is that the initial pH of the culture medium is inconsistent.
[0111] The difference between Comparative Examples 9 and 10 and Example 3 is that the temperature is not controlled in stages during the entire fermentation process, but a fixed value is used.
[0112] The difference between Comparative Example 11 and Example 3 is that the phosphate ion concentration of the culture medium is inconsistent.
[0113] The difference between Comparative Example 12 and Example 3 is that the initial pH of the culture medium is inconsistent.
[0114] Experimental example For Example 1 to Example 3, and Comparative Example 1 to Comparative Example 12, blank group 1 and blank group 2 were set to ferment and obtain fermentation results. The fermentation results are shown in Table 1: Table 1. Fermentation results
[0115] As shown in Table 1, Comparative Example 3 and Example 1, Comparative Example 7 and Example 2, Blank Group 1 and Comparative Example 9, Comparative Example 11 and Example 3 all adopt the same culture temperature and pH value, and only the phosphate ions are different. When the fermentation is carried out for 240 hours, the rapamycin production of the latter is 1.34 times, 1.29 times, 1.21 times, and 1.32 times that of the former; the proportion of rapamycin in the fermentation broth of the latter is 1.24 times, 1.22 times, 1.16 times, and 1.20 times that of the former.
[0116] Comparative Example 4 and Example 1, Comparative Example 8 and Example 2, Comparative Example 12 and Example 3 all use the same culture temperature and phosphate ion, only the pH value is different. When the fermentation is carried out for 240 hours, the rapamycin production of the latter is 4.87 times, 4.78 times, and 5.24 times that of the former; the proportion of rapamycin in the fermentation broth of the latter is 1.40 times, 1.45 times, and 1.38 times that of the former.
[0117] Comparative Examples 1 and 2 and Example 1, Comparative Examples 5 and 6 and Example 2, Comparative Examples 9 and 10 and Example 3 all use the same pH value and phosphate ion, only the culture temperature is controlled differently. When the fermentation is carried out for 240 hours, the rapamycin production of the latter is 1.22 times, 2.56 times, 1.20 times, 1.47 times, 1.23 times, and 2.39 times that of the former; the proportion of rapamycin in the fermentation broth of the latter is 1.14 times, 1.31 times, 1.11 times, 1.27 times, 1.15 times, and 1.35 times that of the former.
[0118] For Example 1, Example 2 and Example 3, the culture temperature is controlled in sections, and the pH value and phosphate ion are also within the control range. Compared with only controlling any two of them in Comparative Examples 1-12, when the fermentation is carried out to 240h, the combined control of the three is better than controlling any two of them. The rapamycin yield and the proportion of rapamycin in the fermentation broth are significantly improved, indicating that the fermentation parameters are not set arbitrarily. This is related to the different metabolic mechanisms of the strain growth period. The three factors cannot be simply set to achieve good results, but require the coordination and reasonable matching of the parameters of each factor. The scheme provided by the present invention enables the three to achieve real synergy, which affects the microbial fermentation, and finally achieves the purpose of significantly increasing the rapamycin yield and increasing the proportion of rapamycin in the fermentation broth.
[0119] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing rapamycin, characterized in that: Based on the fermentation temperature control, the rapamycin strain is processed through four fermentation stages to obtain the rapamycin fermentation liquid, and the rapamycin fermentation liquid is separated and extracted to obtain rapamycin; the fermentation stages include the first fermentation stage, the second fermentation stage, the third fermentation stage and the fourth fermentation stage; the fermentation temperature of the first fermentation stage is 26-30°C, at which time the pH value of the fermentation liquid is the initial pH, the fermentation temperature of the second fermentation stage is 20-24°C, at which time the pH value of the fermentation liquid decreases by 0.5-1 pH units, the fermentation temperature of the third fermentation stage is 25-27°C, at which time the pH value of the fermentation liquid remains unchanged, the fermentation temperature of the fourth fermentation stage is 27-29°C, and the pH value of the fermentation liquid gradually increases to 7.2-7.5; the initial pH of the fermentation medium is 6.2-8.
0.
2. The method for preparing rapamycin according to claim 1, characterized in that: The fermentation environment of the four fermentation stages is a phosphate-containing fermentation medium.
3. The method for preparing rapamycin according to claim 2, characterized in that: The phosphate ion concentration of the fermentation medium is between 0.005% and 0.05%.
4. The method for preparing rapamycin according to claim 1, characterized in that: The dissolved oxygen content in the four fermentation stages is greater than or equal to 60%.
5. The method for preparing rapamycin according to claim 1, characterized in that: The end mark of the first fermentation stage is: the concentration of rapamycin in the fermentation liquid is 10%, and bacterial particles with a size less than 0.1 mm appear.
6. The method for preparing rapamycin according to claim 1, characterized in that: The end mark of the second fermentation stage is: the concentration of rapamycin in the fermentation liquid is 20%-25%, and the size of the bacterial particles develops to 0.5 mm or above.
7. The method for preparing rapamycin according to claim 1, characterized in that: The end mark of the third fermentation stage is: the rapamycin concentration in the fermentation broth is 30%-35%, and the rapamycin concentration in the fermentation broth is increased by 10% based on the second fermentation stage.
8. The method for preparing rapamycin according to claim 1, characterized in that: The end mark of the fourth fermentation stage is: the bacterial concentration is maintained at the second fermentation stage.
Citation Information
Patent Citations
Method for obtaining rapamycin fermentation liquor by culturing actinoplanes
CN103740781A
Fermentation medium and method for fermentation production of rapamycin
CN116769648A
Fermentation preparation method of rapamycin
CN118638878A
